TG THERAPEUTICS, INC.: capex
| Value | {"amount": 2000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | current |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:09.723465+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/aadd3c05-cdc9-413b-8b7f-bd1330953f71
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001654954-19-002189Retrieved: 2026-08-19T09:42:09.723465+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/capex/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/aadd3c05-cdc9-413b-8b7f-bd1330953f71
History
- supersedes {"amount": 2227, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001654954-18-002638)